ConductScience.org, home

Paper498148

Rationale for development of platinum analogs.

Burchenal JH and 3 others. Cancer Treat Rep, 1979. Cited by 116 papers, by iCite.

Cite this record

ConductScience Library. Rationale for development of platinum analogs. Papers, record 498148. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/498148

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rationale for development of platinum analogs.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
4.16
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burchenal JHJ H
2Kalaher KK
3Dew KK
4Lokys LL

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
Leukemia, ExperimentalMajor topic
Animals
Cyclohexylamines
Drug Evaluation, Preclinical
Drug Resistance
Drug Synergism
Drug Therapy, Combination
Mice
Organoplatinum Compounds
Thiourea

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
37454081Study of novel bidentate heterocyclic amine-based metal complexes and their biological activities: cytotoxicity and antimicrobial activity evaluation.BMC Chem2023https://conductscience.org/library/papers/37454081PubMed
36290786Prevention of Testicular Damage by Indole Derivative MMINA via Upregulated StAR and CatSper Channels with Coincident Suppression of Oxidative Stress and Inflammation: In Silico and In Vivo Validation.Antioxidants (Basel)2022https://conductscience.org/library/papers/36290786PubMed
28003740Dose-dependent effects of cisplatin on the severity of testicular injury in Sprague Dawley rats: reactive oxygen species and endoplasmic reticulum stress.Drug Des Devel Ther2016https://conductscience.org/library/papers/28003740PubMed
26691229The effects of MOTILIPERM on cisplatin induced testicular toxicity in Sprague-Dawley rats.Cancer Cell Int2015https://conductscience.org/library/papers/26691229PubMed
24874729Systems biology of cisplatin resistance: past, present and future.Cell Death Dis2014https://conductscience.org/library/papers/24874729PubMed
15726120
Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group.
Br J Cancer2005https://conductscience.org/library/papers/15726120PubMed
9472630In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.Br J Cancer1998https://conductscience.org/library/papers/9472630PubMed
8080724Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.Br J Cancer1994https://conductscience.org/library/papers/8080724PubMed
7981487New platinum agents. A comparison in ovarian cancer.Drugs Aging1994https://conductscience.org/library/papers/7981487PubMed
7850917Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7850917PubMed
7031350[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].Klin Wochenschr1981https://conductscience.org/library/papers/7031350PubMed
3935149Chemopotentiation of mitomycin C cytotoxicity in vitro by platinum complexes.Br J Cancer1985https://conductscience.org/library/papers/3935149PubMed
3910609Comparative cytotoxicity between cisplatin and second generation platinum analogs.Invest New Drugs1985https://conductscience.org/library/papers/3910609PubMed
3293840Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3293840PubMed
3048763Resistance to cisplatin and analogues: mechanisms and potential clinical implications.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3048763PubMed
2803953Cisplatin/carboplatin cross-resistance in ovarian cancer.Br J Cancer1989https://conductscience.org/library/papers/2803953PubMed
2679841Acute and cumulative effects of carboplatin on renal function.Br J Cancer1989https://conductscience.org/library/papers/2679841PubMed
2653399Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.Br J Cancer1989https://conductscience.org/library/papers/2653399PubMed
2229134Sensitivity of rodent osteosarcoma clones to platinum-containing phosphonic acid complexes in vitro.J Cancer Res Clin Oncol1990https://conductscience.org/library/papers/2229134PubMed
1906857Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.Jpn J Cancer Res1991https://conductscience.org/library/papers/1906857PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/498148

GET https://conductscience.org/api/papers/v1/498148/cited_by?page=2